| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kairos Pharma, LTD. | VP of Research and Development | COMMON STOCK | 299,529 | $329,481 | $1.10 | 08 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | 08 Oct 2025 | 1 | $0 | 4 | VP of Research and Development | 26 Nov 2025, 18:50 |
| KAPA | Kairos Pharma, LTD. | 01 Jan 2025 | 1 | $0 | 4 | VP of Research and Development | 24 Feb 2025, 18:52 |
| KAPA | Kairos Pharma, LTD. | 25 Nov 2024 | 1 | +$318 | 4 | VP of Research and Development | 25 Nov 2024, 20:30 |
| KAPA | Kairos Pharma, LTD. | 16 Sep 2024 | 0 | $0 | 3 | VP of Research and Development | 24 Sep 2024, 21:00 |